INTRODUCTION
HIV has been found in blood, semen, vaginal secretions, tears, saliva, breast milk, and bloody body fluids, and transmission has occurred via sexual contact semen donation, blood and blood products, sec;etions and excretions with visible blood contamination, breast feeding, and perinatally from mother to infant.
Nosocomial transmission of HIV infection relates to the spread of HIV within the health care setting. Transmission may occur from infected blood productl organ to patient, patient to patient,~ected health care worker to patient, and infected patient to health care worker. We look at each of these routes of nosocomial infection, and at current methods for the prevention of nosocomial infection.
TRANSMISSION VIA BLOOD PRODUCTS, SEMEN AND HUMAN ORGANS
Historically this has been the principal ro~te for nosocomial infection. Prior to HIV screemng of donated blood in the United States it is estimated that 12000 transfusion recipients became infected with the virus and approximately 2.5% of AIDS cases reported to the Centers for Disease Control (CDC) have been related to blood transfusion", By December 1993in the UK, 390AIDS cases had been notified in recipients of blood factors, of whom 330 had died, and 94 AIDS cases in people who had received donor blood or tissue, of whom 64 had died 2 In the UK all blood donors are unpaid volunteers and are asked about risk of exposure to infection and questioned about their health.
The prevalence of anti-HIV-1 and -2 donations amongst new donors in the UK is estimated to be about one in 26()()()4. The risk of contracting HIV from transfusion has been put at less than one in one million donations in the UK. The risk of transmitting infection depends upon the blood components given. All cellular products and some plasma products (e.g. cryoprecipitate and fresh frozen plasma (FFP» cannot be pasteurized or treated by other virucidal processes and thus are capable of transmitting infections.
Even in countries with a high prevalence of HlV infection and poor resources donor deferral has been shown to be feasible and potentially effective in reducing the risk for HIV transmission via transfusion .
There are several documented cases of blood product recipients receiving HIV antibody negative blood and seroconverting for HIV. Subsequent analysis of the donor blood has found to be HIV antigen positive or HIV sequences have been found with pCR6, 7,8. Since the introduction of HIV screening in 1985 there are 4 reports of HIV-1 transmission following organ and tissue donation. In one case the donor tested false negative for HIV due to a massive blood transfusion causing haemodilution of HIV antibody9; in another the donor seroconverted after having been screened 8 months before donation10. In the third, urgent transplantation was performed before the donor's positive HIV result became available!'. The fourth case is of a single organ donor who was HIV negative with no identified risk factors for HIV, but 7 identified recipients became HIV positive. HIV infection in the donor was established by detection of reverse transcriptase, HlV-1 p24 antigen and HIV-1 proviral DNA by peR in cultured spleen tissue 12 •
Restrictive use of blood products
The risk of transmission of HIV can be reduced by the development of clear guidelines for the use of blood products, and the use of autologous blood. Autologous transfusion includes preoperative au. tologous donation, intraoperative and postoperahve International Journal of SID & AIDS Volume 5 July/August 1994 blood salvage and acute normovolaemic haemodilution (usually done immediately preceding surgery). In the United States 6% of blood used is autologous donation and 60% of the blood donated preoperatively is returned to the patient at elective surgery. A pilot report from Newcastle found that preoperative autologous donation accounted for 0.4% of blood used in the Region and that three-quarters of the units were used 13.
TRANSMISSION FROM PATIENT TO PATIENT
Transmission of HIV infection from patient to patient may occur via contaminated medical equipment used for invasive procedures or via perinatal exposure to infected maternal blood/breast milk.
To date there has only been one report of betweenpatient transmission where recommended infection control procedures were practised. This involves 5 HIV positive patients of whom 4 had no recognized risk factors for HIV infection and, on investigation, were found to have had minor surgery in the same room on the same day14. Three females had symptoms consistent with seroconversion within a month of their surgery, and investigation of the patient with risk factors for HIV showed him to have a low CD4 count 10 months following his operation, suggesting that his HIV infection pre-dated the surgery. The mechanism of transmission is unclear.
Guidelines for prevention of infection between patients include the use of disposable injection equipment if a large supply of needles and syringes is available and if used equipment can be disposed of safely. Non-disposable equipment must be able to be safely decontaminated after use 15.
Haemodialysis
Procedures for decontamination of equipment are necessary that will destroy HIV in the fluid pathways of the haemodialysis machine. Routines using sodium hypochlorite solution or chloramine compounds in concentrations securing the presence of 1000 parts per million (ppm) free chlorine for 60 minutes or 2% glutaraldehyde left overnight are satisfactory after dialyzing HIV infected patients.
Intrapartum transmission of HIV infection
There is still much debate on the timing of transmission of HIV to infants of infected mothers. However, the results of a study looking at twins born to HIV-infected mothers suggest that a substantial proportion of HIV transmission occurs as the first twin encounters the cervix and birth canal, and that caesarean section may have some preventive effect. Fifty per cent of first-born twins delivered vaginally and 38% of first-born twins delivered by caesarean were infected, compared with 19% of second-born twins delivered by other routes", A meta-analysis on the published data on the relation between mode of delivery and percentage of infected children, found a lower rate for operative deliveryl", A specific randomized trial evaluating the risk of method of transmission of HIV for operative and vaginal delivery is now under way in Italy18.
An interim review of the AIDS clinical trial group (AcrG) study 076 suggests that HIV transmission to the newborn can be significantly reduced by zidovudine therapy. The study revealed a transmission rate of 8.3% when mothers received zidovudine during both pregnancy and labour and babies received zidovudine for the first 6 weeks of life, and 25.5% among those who received placebo",
Breast feeding
It has been suggested that breast feeding increases the risk of perinatal infection by approximately 14%. Advice to an HIV-infected mother on feeding an infant will depend on the risk of bottle feeding (and infectious diseases) versus the risk of acquiring HIV infection-". In the UK, current recommendations would usually be to bottlefeed.
TRANSMISSION FROM INFECTED HEALTH CARE WORKER TO PATIENT
The risk of HIV transmission to a patient from an infected health care worker (HCW) is much less than with hepatitis B21,22. Infectivity of HIV varies between individuals and over time for a single individual and, for any individual, the risk of transmission is greatest during exposure prone invasive procedures. These are procedures in which injury to the HCW could result in that person's blood contaminating the patient's open tissue; e.g. when hands may be in contact with sharp instruments or sharp tissues (splinters of bone or teeth) inside a patient's body cavity or open wound, and particularly when the hands are not completely visible 23 • The CDC has defined invasive procedures as ,surgical entry into tissues, cavities or organs or repair of major traumatic injuries' associated with any of the following: '1) an operating or delivery room, emergency department or out patient setting, including both physicians' and dentists' offices; 2) cardiac catheterization and angiographic procedures; 3) a vaginal or Caesarean delivery or other invasive obstetric procedure during which bleeding may occur; or 4) the manipulation, cutting or removal of any oral or perioral tissues, including tooth structure, during which bleeding occurs or the potential for bleeding exists'24.
The investigation of a Florida dentist with AIDS concluded that HN infection was transmitted to 6 (0.5%) of 1100 patients who were evaluated's, although the mechanism of transmission remains unclear2 4 . By March 1993 the CDC had HN results for 19036 patients who were treated by another 57 HN infected HCWs. No HN positive patients were reported among those treated by 46 of these HCWs. Of the remaining 11 (6 dentists and 5 surgeons/obstetricians) there were 92 cases of HN infection among 7507patients tested. The degree of enetic similarity of viruses from patients and infected HCWs was in the range previously reported from persons with epidemiologically unrelated infections 25 • 
Recommendations for prevention of infection from infected HeWs
The revised guidance from the Department of Health 23 1993 states that HCWs who believe they may have been exposed to HN infection, in Whatever circumstances, must seek medical advice and HN antibody testing if applicable. HN-infected HCWs who continue to work with patients must remain under close medical supervision and receive appropriate medical and occupational advice as their Cll'cumstances change. HN-infected HCWs who perf?rm exposure prone invasive procedures must obt~expert medical advice on their work practices, which may need to be modified in order to protect patients and those who have undertaken exposure prone procedures must cease these activities and they~or their occupational physician must inform, in confidence, the senior medical manager designated by their employer. Responsibility for deciding whether the exposed patients need to be informed Worldwide, by September 1993, there were 64 documented seroconversions and 118 cases of possible occupationally-acquired HIV infections/", !r~smission most commonly followed needlestick mJury, usually with a hollow needle. Transmission has, however, also followed contact between the skin or mucous membranes and HN infected blood during the provision of health care.
Prospective studies investigating transmission rates of HN following occupational exposure to virus via percutaneous injury in 2475 cases give a risk of seroconversion of 0.36%28. In a similar study of >1100HCWs with mucous membrane exposure there was only one seroconversion giving an estimated transmission rate of 0.09%29 and the risk of transmission following. cutaneous exposure is probably smaller with no seroconversions after > 2700 exposures'", To date no documented cases of HN transmission have occurred during life support resuscitation. Gloves and aprons should be worn and expired air ventilation should be performed using a protective device.
However, resuscitation must not be delayed to meet these requirements Resuscitation training manikins have not been shown to be a source of virus infection. In order to minimize the potential for occupational transmission face shields and disposable face pieces should be used when possible and the manikin must be disinfected after each use 31 • Precautions against occupational exposure 'Universal precautions' 'Universal precautions' stress that all patients should be assumed to be infectious for HIV and other blood-borne pathogens.
The recommended precautions covering all activities undertaken by HCWs are set out in guidelines from the UK health departments". Primary measures for prevention of occupational exposure include the protection of existing wounds and skin lesions, and the prevention of puncture wounds and abrasions in the presence of blood and body fluids; the application of simple protective measures to avoid contamination of the person with blood and good basic hygiene practices; control of work surface contamination with blood and body fluids by containment and disinfection; avoidance of sharps usage where possible and the exercising of particular care in their handling and disposal; and the safe disposal of clinical waste.
Specific measures relating to sharps include, not resheathing needles unless there is a safe means for doing so, not removing needles from syringes unless essential, and promptly placing all disposable sharps in a puncture-resistant bin for incineration.
Post-exposure management
Following an inoculation injury the puncture should be encouraged to bleed by squeezing the area. The wound should be thoroughly washed with soap and water. Splashes into the eye should be washed immediately with sterile eye-wash solution or clean water. Splashes into the mouth should be irrigated with copious volumes of clean water 15 . Any incident involving occupational exposure of HCWs must be promptly reported to the person designated to record such incidents 15 • Advice should be sought from a designated medical adviser to plan the course of further action such as investigation of the patient's HN status, and the adoption of protective measures such as hepatitis Bvaccination or the use of zidovudine.
